← back to search

Toby Pillinger

King's College London · GB
Area of research
Psychiatry and Mental health · Biological Psychiatry
Research interest
Research interests include Schizophrenia research and treatment, Tryptophan and brain disorders, Treatment of Major Depression, and Diet and metabolism studies.
h-index
31
citations
7,108
works
121
NIH funding
primary concept
email

Recent publications

Real‐world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stages
World Psychiatry 2026cited by 5position: middledoi
Glucagon-Like Peptide 1 Receptor Agonists and Mental Health
JAMA Psychiatry 2025cited by 56position: lastdoi
INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia
The Lancet Psychiatry 2025cited by 55position: middledoi
Incidence and Nature of Antidepressant Discontinuation Symptoms
JAMA Psychiatry 2025cited by 25position: middledoi
The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis
The Lancet 2025cited by 22position: firstdoi
Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel
The Lancet Psychiatry 2025cited by 16position: middledoi
Brain and body energy metabolism and potential for treatment of psychiatric disorders
Nature Mental Health 2025cited by 15position: middledoi
Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health Commission
The Lancet Psychiatry 2025cited by 14position: middledoi
Prevalence of multimorbidity in people with and without severe mental illness: a systematic review and meta-analysis
The Lancet Psychiatry 2024cited by 66position: middledoi
Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation
Schizophrenia Bulletin 2024cited by 38position: middledoi
Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis
The Lancet Child & Adolescent Health 2024cited by 27position: lastdoi
Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development
The Lancet Psychiatry 2023cited by 129position: firstdoi
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression
Molecular Psychiatry 2023cited by 72position: middledoi
Effect of polygenic risk for schizophrenia on cardiac structure and function: a UK Biobank observational study
The Lancet Psychiatry 2023cited by 46position: firstdoi
Shared and separate patterns in brain morphometry across transdiagnostic dimensions
Nature Mental Health 2023cited by 24position: middledoi
Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis
Psychoneuroendocrinology 2023cited by 12position: middledoi
Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends
Neuroscience & Biobehavioral Reviews 2022cited by 207position: middledoi
Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of <sup>18</sup>FDG-PET studies in schizophrenia
Psychological Medicine 2022cited by 62position: middledoi
Reappraising the variability of effects of antipsychotic medication in schizophrenia: a meta‐analysis
World Psychiatry 2022cited by 49position: middledoi
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study
The British Journal of Psychiatry 2022cited by 30position: middledoi
Variability of glucose, insulin, and lipid disturbances in first-episode psychosis: a meta-analysis
Psychological Medicine 2022cited by 25position: firstdoi
Treatment resistance in psychiatry: state of the art and new directions
Molecular Psychiatry 2021cited by 379position: lastdoi
Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls
Schizophrenia Research 2021cited by 63position: lastdoi
Inflammatory markers in depression: A meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls
Brain Behavior and Immunity 2020cited by 869position: middledoi
Cardiac structure and function in schizophrenia: cardiac magnetic resonance imaging study
The British Journal of Psychiatry 2020cited by 31position: middledoi
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
The Lancet Psychiatry 2019cited by 1,484position: middledoi
Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis
The Lancet Psychiatry 2019cited by 987position: firstdoi
The efficacy and heterogeneity of antipsychotic response in schizophrenia: A meta-analysis
Molecular Psychiatry 2019cited by 88position: middledoi
Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications
Psychopharmacology 2019cited by 51position: firstdoi
Cardiac structure and function in patients with schizophrenia taking antipsychotic drugs: an MRI study
Translational Psychiatry 2019cited by 49position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Oliver Howes · King's College London26 papers (2017–2025)Robert A. McCutcheon · Oxford Health NHS Foundation Trust21 papers (2017–2025)Enrico D’Ambrosio · University of Bari Aldo Moro6 papers (2017–2025)Sameer Jauhar · Imperial College London6 papers (2017–2025)Katherine Beck · King's College London5 papers (2017–2022)Andrea Cipriani · Oxford Health NHS Foundation Trust5 papers (2019–2025)Emanuele F. Osimo · Cambridge University Hospitals NHS Foundation Trust5 papers (2018–2023)Maria Rogdaki · King's College London5 papers (2017–2024)Fiona Gaughran · King's College London4 papers (2021–2024)Christoph U. Correll · Champlain Regional College4 papers (2022–2025)Stefan Brugger · University of Bristol4 papers (2018–2023)Allan H. Young · Kingsley House4 papers (2022–2025)Tiago Reis Marques · King's College London4 papers (2017–2022)Declan P. O’Regan · Imperial College Healthcare NHS Trust3 papers (2019–2023)Antonio de Marvao · St Thomas' Hospital3 papers (2019–2023)Luke Vano · King's College London3 papers (2019–2023)Marco Solmi · University of Ottawa3 papers (2021–2025)Dan Siskind · The Behaviouralist (United Kingdom)3 papers (2021–2024)Stefan Leucht · KUKA (Germany)3 papers (2022–2024)David Taylor · Columbia University3 papers (2022–2025)